Inagaki, Chiaki
Kawakami, Hisato http://orcid.org/0000-0002-3280-4850
Maeda, Daichi
Sakai, Daisuke
Urakawa, Shinya
Nishida, Kentaro
Kudo, Toshihiro
Doki, Yuichiro
Eguchi, Hidetoshi
Wada, Hisashi
Satoh, Taroh
Article History
Received: 25 January 2023
Accepted: 30 March 2023
First Online: 6 April 2023
Competing interests
: C. Inagaki has received lecture fees from MSD K.K., and Taiho Pharmaceutical Co., Ltd., and has received research funding from Eisai Co., Ltd, Ono Pharmaceutical Co., Ltd., and Astellas pharm Inc. H. Kawakami has received consulting fees from Bristol-Myers Squibb Co., Ltd., Eli Lilly Japan K.K., MSD K.K., Ono Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., and Taiho Pharmaceutical Co., Ltd.; honoraria from Bristol-Myers Squibb Co., Ltd., AstraZeneca K.K., Eli Lilly Japan K.K., MSD K.K., Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd.; lecture fees from Bristol-Myers Squibb Co., Ltd., Eli Lilly Japan K.K., MSD K.K., Ono Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd.; and research funding from Bristol-Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Eisai Co., Ltd. D. Maeda has nothing to disclose. D. Sakai belong to the Department of Frontier Science for Cancer and Chemotherapy, which is a donated department supported by Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd. S. Urakawa belong to the Department of Clinical Research in Tumor Immunology, which is a joint research laboratory with Sionogi & Co., Ltd. K. Nishida belong to the Department of Clinical Research in Tumor Immunology, which is a joint research laboratory with Sionogi & Co., Ltd. T. Kudo has nothing to disclose. Y. Doki has received lecture fee from Ono Pharmaceutical Co., Ltd. H. Eguchi has received grant from Taiho Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Menicon Co., Ltd., Mitsubishi Tanabe Pharma Corporation. H. Wada is a professor of the Department of Clinical Research in Tumor Immunology, which is a joint research laboratory with Sionogi & Co., Ltd., and has received lectures fees from Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd, and MSD K. K. T. Satoh has served as a professor of Department of Frontier Science for Cancer and Chemotherapy, which is a donated department supported by Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd.